The rapid growth of GLP 1 weight management therapies is beginning to reshape how consumers approach food. As these treatments move beyond specialist use into the mainstream, they are influencing expectations around portion size, satiety, nutrient density and added functionality.
For food & beverage manufacturers, this shift presents both an opportunity and a challenge. Products positioned to “support” GLP 1 users, are emerging, often combining ingredients with specific functionalities linked to satiety and nutrient density. However, translating these concepts into market-ready products requires careful navigation of an evolving and fragmented regulatory landscape.
Understanding the regulatory implications for GLP-1 support foods
From a regulatory perspective, GLP-1 support foods sit in largely unchartered territory. Existing frameworks for foods and supplements were not designed with these products in mind. As a result, authorities across key markets are increasingly scrutinising how such products should be classified, how far positioning can go, and whether current rules adequately address emerging product formats and claims.
For businesses looking to innovate in this space, anticipating regulatory expectations – rather than reacting to them – will be critical to avoiding delays, reformulation or market access challenges.
Leatherhead Food Research’s latest report, GLP-1 Support Foods for Weight Management, explores the key regulatory considerations across 17 markets, including:
- How foods marketed as “GLP 1 support foods” may be classified within existing regulatory categories
- Where the line sits between general nutritional messaging and regulated health or functional claims
- How differing regulatory pathways across global markets can affect labelling, substantiation requirements and speed to market
Global regulatory diversity is already emerging
One of the defining features of this category is the lack of global harmonisation. Regulatory treatment of GLP-1 support foods varies significantly between markets, creating complexity for companies operating internationally:
- EU/UK – Explicit references to GLP-1 are not permitted, and weight management claims remain tightly controlled within specific regulated categories such as meal replacements
- Japan/Brazil – Limited GLP-1 claims may be possible via specialist/health channels; however approval is not guaranteed and first-movers face high risk
- USA/Australia & New Zealand/India – There may be limited scope to reference GLP-1 through self-substantiated claims, but this carries increased compliance risk
For global brands, aligning product positioning, claims and labelling strategies across these differing frameworks will be a key challenge.
Access further insight
Leatherhead Food Research Members can access detailed, country-by country analysis in the 2026 Regulatory Insight Report on “GLP-1 Support Foods”, where the Nominated Representative has selected this report as part of their membership.
Members who have already chosen this report are invited to join our complementary webinar on Wednesday June 3, 2026, where our global regulatory experts will explore these developments in more depth and answer Members’ questions live.
To access the report or register for the webinar, please contact the team at [email protected]
Read our latest blogs
May 22, 2026
GLP-1 support foods: Navigating evolving regulations for compliant market launches
May 21, 2026
Governments strengthen mandatory food fortification frameworks: implications for global compliance